Information about the AIM Study, GPS for the Body Technology, Reducing Side Effects of IMRT and More
Clinical research demonstrates that tracking prostate motion during radiation therapy allows a reduction in the planning target volume (PTV), resulting in fewer patient-reported side effects. Summaries of our clinical research highlights, clinical presentations and other materials have been assembled to demonstrate how to incorporate real-time tracking into your treatment regimen and to increase the quality of life for your patients.
The primary objective of the Assessing the Impact of Margin Reduction (AIM) Study was to measure the effect of reduced planning target volume (PTV) in prostate cancer patients undergoing high dose intensity modulated radiation therapy (IMRT) as measured by patient-reported outcomes.
Millimeters Matter - What You Need To Know About Organ Motion During Prostate Radiation Therapy
Organ motion is prevalent, variable, and unpredictable during radiation therapy, and therefore presents challenges to delivering precise external beam radiation to the prostate.
GPS for the Body® Technology - How Does it Work?
Clinicians use the motion data provided by the Calypso® System to guide radiation therapy setup and monitor the prostate position during treatment delivery.
Clinical Education Presentation
The clinician education presentation provides an overview about organ motion during prostate radiation therapy. It also contains a complete overview of the Calypso System and a summary of clinical study findings.